A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration – resistant prostate cancer patients responding to chemotherapy

PURPOSE: To investigate the toxicity and efficacy of GM-CSF in castration-resistant prostate cancer (CRPC) patients who maximized their response to systemic chemotherapy. MATERIALS AND METHODS: CRPC patients who maximized their response to either docetaxel or mitoxantrone chemotherapy were eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabhan, Chadi, Meyer, Andrew, Tolzien, Kathy, Bitran, Jacob D., Lestingi, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507059/
https://www.ncbi.nlm.nih.gov/pubmed/23210004
http://dx.doi.org/10.4103/2231-0770.83718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507059/
https://www.ncbi.nlm.nih.gov/pubmed/23210004
http://dx.doi.org/10.4103/2231-0770.83718

Ejemplares similares